These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

309 related articles for article (PubMed ID: 28605159)

  • 1. Differential Impact of Weight Loss on Nonalcoholic Fatty Liver Resolution in a North American Cohort with Obesity.
    Rachakonda V; Wills R; DeLany JP; Kershaw EE; Behari J
    Obesity (Silver Spring); 2017 Aug; 25(8):1360-1368. PubMed ID: 28605159
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of Nonalcoholic Fatty Liver Disease With Visceral Adiposity but Not Coronary Artery Calcification in the Elderly.
    Jacobs K; Brouha S; Bettencourt R; Barrett-Connor E; Sirlin C; Loomba R
    Clin Gastroenterol Hepatol; 2016 Sep; 14(9):1337-1344.e3. PubMed ID: 26820400
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Noninvasive Markers of Improvement of Liver Steatosis Achieved by Weight Reduction in Patients with Nonalcoholic Fatty Liver Disease.
    Copaci I; Lupescu I; Caceaune E; Chiriac G; Ismail G
    Rom J Intern Med; 2015; 53(1):54-62. PubMed ID: 26076562
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nonalcoholic Fatty Liver Disease in The Rotterdam Study: About Muscle Mass, Sarcopenia, Fat Mass, and Fat Distribution.
    Alferink LJM; Trajanoska K; Erler NS; Schoufour JD; de Knegt RJ; Ikram MA; Janssen HLA; Franco OH; Metselaar HJ; Rivadeneira F; Darwish Murad S
    J Bone Miner Res; 2019 Jul; 34(7):1254-1263. PubMed ID: 31074909
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Beneficial effects of lifestyle intervention in non-obese patients with non-alcoholic fatty liver disease.
    Wong VW; Wong GL; Chan RS; Shu SS; Cheung BH; Li LS; Chim AM; Chan CK; Leung JK; Chu WC; Woo J; Chan HL
    J Hepatol; 2018 Dec; 69(6):1349-1356. PubMed ID: 30142427
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Improvements in clinical characteristics of patients with non-alcoholic fatty liver disease, after an intervention based on the Mediterranean lifestyle: a randomised controlled clinical trial.
    Katsagoni CN; Papatheodoridis GV; Ioannidou P; Deutsch M; Alexopoulou A; Papadopoulos N; Papageorgiou MV; Fragopoulou E; Kontogianni MD
    Br J Nutr; 2018 Jul; 120(2):164-175. PubMed ID: 29947322
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lifestyle intervention for morbid obesity: effects on liver steatosis, inflammation, and fibrosis.
    Hohenester S; Christiansen S; Nagel J; Wimmer R; Artmann R; Denk G; Bischoff M; Bischoff G; Rust C
    Am J Physiol Gastrointest Liver Physiol; 2018 Sep; 315(3):G329-G338. PubMed ID: 29878845
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Regular exercise coupled to diet regimen accelerates reduction of hepatic steatosis and associated pathological conditions in nonalcoholic fatty liver disease.
    Oh S; Tanaka K; Tsujimoto T; So R; Shida T; Shoda J
    Metab Syndr Relat Disord; 2014 Jun; 12(5):290-8. PubMed ID: 24689911
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Skeletal muscle mass to visceral fat area ratio is an important determinant affecting hepatic conditions of non-alcoholic fatty liver disease.
    Shida T; Akiyama K; Oh S; Sawai A; Isobe T; Okamoto Y; Ishige K; Mizokami Y; Yamagata K; Onizawa K; Tanaka H; Iijima H; Shoda J
    J Gastroenterol; 2018 Apr; 53(4):535-547. PubMed ID: 28791501
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term effects of aerobic plus resistance training on the adipokines and neuropeptides in nonalcoholic fatty liver disease obese adolescents.
    de Piano A; de Mello MT; Sanches Pde L; da Silva PL; Campos RM; Carnier J; Corgosinho F; Foschini D; Masquio DL; Tock L; Oyama LM; do Nascimento CM; Tufik S; Dâmaso AR
    Eur J Gastroenterol Hepatol; 2012 Nov; 24(11):1313-24. PubMed ID: 22932160
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relationship between the Bertin index to estimate visceral adipose tissue from dual-energy X-ray absorptiometry and cardiometabolic risk factors before and after weight loss.
    Karelis AD; Rabasa-Lhoret R; Pompilus R; Messier V; Strychar I; Brochu M; Aubertin-Leheudre M
    Obesity (Silver Spring); 2012 Apr; 20(4):886-90. PubMed ID: 21869764
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sarcopenia is associated with significant liver fibrosis independently of obesity and insulin resistance in nonalcoholic fatty liver disease: Nationwide surveys (KNHANES 2008-2011).
    Lee YH; Kim SU; Song K; Park JY; Kim DY; Ahn SH; Lee BW; Kang ES; Cha BS; Han KH
    Hepatology; 2016 Mar; 63(3):776-86. PubMed ID: 26638128
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Relationship between sarcopenia and nonalcoholic fatty liver disease: the Korean Sarcopenic Obesity Study.
    Hong HC; Hwang SY; Choi HY; Yoo HJ; Seo JA; Kim SG; Kim NH; Baik SH; Choi DS; Choi KM
    Hepatology; 2014 May; 59(5):1772-8. PubMed ID: 23996808
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Management of non-alcoholic fatty liver disease in patients with sarcopenia.
    Hsu CS; Kao JH
    Expert Opin Pharmacother; 2022 Feb; 23(2):221-233. PubMed ID: 34541964
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of longitudinal changes of body fat on the incidence and regression of nonalcoholic fatty liver disease.
    Kim D; Chung GE; Kwak MS; Kim YJ; Yoon JH
    Dig Liver Dis; 2018 Apr; 50(4):389-395. PubMed ID: 29373238
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association of Visceral Fat Obesity, Sarcopenia, and Myosteatosis with Non-Alcoholic Fatty Liver Disease without Obesity.
    Kim HK; Bae SJ; Lee MJ; Kim EH; Park H; Kim HS; Cho YK; Jung CH; Lee WJ; Choe J
    Clin Mol Hepatol; 2023 Oct; 29(4):987-1001. PubMed ID: 37403320
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association of nonalcoholic fatty liver disease with cardiovascular risk factors in obese adolescents: the role of interdisciplinary therapy.
    Sanches PL; de Piano A; Campos RM; Carnier J; de Mello MT; Elias N; Fonseca FA; Masquio DC; da Silva PL; Corgosinho FC; Tock L; Oyama LM; Tufik S; Dâmaso AR
    J Clin Lipidol; 2014; 8(3):265-72. PubMed ID: 24793347
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Agreement of bioelectrical impedance with dual-energy X-ray absorptiometry and MRI to estimate changes in body fat, skeletal muscle and visceral fat during a 12-month weight loss intervention.
    Pietiläinen KH; Kaye S; Karmi A; Suojanen L; Rissanen A; Virtanen KA
    Br J Nutr; 2013 May; 109(10):1910-6. PubMed ID: 22935366
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Body Fat Distribution and Risk of Incident and Regressed Nonalcoholic Fatty Liver Disease.
    Kim D; Chung GE; Kwak MS; Seo HB; Kang JH; Kim W; Kim YJ; Yoon JH; Lee HS; Kim CY
    Clin Gastroenterol Hepatol; 2016 Jan; 14(1):132-8.e4. PubMed ID: 26226099
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Age-Related Decrease in Skeletal Muscle Mass Is an Independent Risk Factor for Incident Nonalcoholic Fatty Liver Disease: A 10-Year Retrospective Cohort Study.
    Lee MJ; Kim EH; Bae SJ; Kim GA; Park SW; Choe J; Jung CH; Lee WJ; Kim HK
    Gut Liver; 2019 Jan; 13(1):67-76. PubMed ID: 30037166
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.